Hemicrania Continua Treatment
Indomethacin is the definitive treatment for hemicrania continua, starting at 25-50 mg three times daily and titrating up to 150-225 mg/day until complete headache resolution is achieved 1, 2, 3.
First-Line Treatment: Indomethacin
The absolute response to therapeutic doses of indomethacin is not just the treatment—it's actually a diagnostic criterion for hemicrania continua 2. This dramatic response distinguishes HC from migraine and other headache disorders that don't respond to indomethacin 3.
Dosing strategy:
- Start at 25-50 mg three times daily
- Titrate upward as needed
- Therapeutic range typically 150-225 mg/day
- Use the lowest clinically effective dose for long-term management 1
- Always prescribe with a proton pump inhibitor to prevent GI complications
Alternative NSAIDs (When Indomethacin is Not Tolerated)
If indomethacin causes intolerable side effects, consider these alternatives in order of evidence strength:
For acute treatment:
For chronic prevention:
The newer COX-II inhibitors show promise with potentially better GI tolerability 3.
Emerging Non-Pharmacologic Option
Noninvasive vagus nerve stimulation has recently shown efficacy and can be either indomethacin-sparing or, in some cases, headache-controlling as monotherapy 1. This represents an important breakthrough for patients who cannot tolerate NSAIDs long-term.
Additional Preventive Options (Third-Line)
When NSAIDs fail or are contraindicated:
These have shown "good results" but are clearly inferior to indomethacin and other NSAIDs 4.
Critical Diagnostic Workup
Brain MRI with dedicated pituitary views is mandatory when HC is identified, given the lifelong nature of the condition 1. While secondary cases exist (such as from paravertebral tumors impinging on the sympathetic chain 6), the syndrome and response to treatment remain similar to primary HC 3. Importantly, higher indomethacin dose requirements do NOT reliably predict secondary pathology, contrary to early reports 3.
Common Diagnostic Pitfalls
- Missing the diagnosis entirely: HC is often misdiagnosed and treated as migraine because patients may present with migraine-like features including nausea, photophobia, phonophobia, and even aura 3
- Lack of cranial autonomic symptoms: Some patients don't display obvious autonomic features, which can confound diagnosis 3
- Prior episodic pattern: Patients may have had days-long episodic patterns before developing continuous pain 3
- Medication overuse: The tendency toward analgesic exacerbation further deflects from the correct diagnosis 3
The key distinguishing feature remains the absolute response to indomethacin—something not seen in migraine or other trigeminal autonomic cephalalgias 3.